The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial. - Emery,P.; Fleischmann,R.; Filipowicz-Sosnowska,A. (Arthritis Rheum, 2006)